PSAPs vs. Hearing Aids vs. OTC: What's the Difference?
The FDA regulates three categories of devices that amplify sound: prescription hearing aids, over-the-counter hearing aids, and personal sound amplification products (PSAPs). The first two are regulated as medical devices intended to treat hearing loss. The third is not, and that distinction is legally enforced.
Key takeaways
- Three FDA categories exist: prescription hearing aids (Class I/II medical devices, 510(k) cleared), over-the-counter hearing aids (Class I/II medical devices, De Novo authorized or OTC rule compliant), and PSAPs (not medical devices).
- PSAPs are not intended for hearing loss. They are consumer electronics for non-hearing-impaired people who want to amplify environmental sounds for recreation.
- 21 CFR 800.30 restricts PSAP marketing. PSAPs cannot claim to treat, diagnose, or mitigate hearing impairment, and manufacturers face enforcement if they market to people with hearing loss.
- "FDA registered" is not a quality badge. It is an administrative requirement, not evidence of FDA review, clearance, or authorization.
- If you have hearing loss, use a hearing aid. OTC for mild to moderate loss, prescription for severe loss or complex needs.
The FDA recognizes three categories of devices that amplify sound: prescription hearing aids, over-the-counter hearing aids, and personal sound amplification products (PSAPs). The first two are medical devices regulated under 21 CFR 874.3300 (prescription) and the OTC final rule (87 FR 50698). The third is not a medical device and is restricted from being marketed to people with hearing loss under 21 CFR 800.30. The categories look similar, but the legal and clinical distinctions matter.
The three FDA categories
The FDA divides sound amplification devices into three buckets based on intended use:
- Prescription hearing aids are Class I or Class II medical devices intended to compensate for impaired hearing. They require 510(k) clearance, are fitted by an audiologist or licensed hearing aid specialist to an audiogram, and are regulated under 21 CFR 874.3300. They can serve any severity of hearing loss and any age.
- Over-the-counter (OTC) hearing aids are Class I or Class II medical devices intended to compensate for perceived mild to moderate hearing impairment in adults 18 and older. They are either De Novo authorized (like certain AirPods Pro and Galaxy Buds models) or comply with the OTC final rule (87 FR 50698, effective October 17, 2022). They can be sold directly to consumers without a prescription or professional fitting.
- Personal sound amplification products (PSAPs) are not medical devices. They are intended for non-hearing-impaired consumers who want to amplify environmental sounds in specific recreational situations (birdwatching, hunting, lectures, theaters). PSAPs are regulated under 21 CFR 800.30, which restricts their labeling and marketing to prevent them from being sold as hearing loss treatments.
The intended use is what separates the categories, and the FDA enforces the boundary. A device marketed to treat hearing loss is a medical device whether the manufacturer calls it one or not, and a device marketed for recreational amplification to people without hearing loss is a PSAP even if it is technically capable of more.
Side-by-side comparison: prescription, OTC, and PSAP
| Prescription hearing aids | OTC hearing aids | PSAPs | |
|---|---|---|---|
| FDA regulatory status | Class I/II medical device, 510(k) cleared | Class I/II medical device, De Novo authorized or OTC rule compliant | Not a medical device |
| Intended use | Compensate for impaired hearing (any severity) | Compensate for perceived mild to moderate hearing impairment | Amplify environmental sounds for non-hearing-impaired users |
| Who can use them | Any age, any severity of hearing loss | Adults 18+, perceived mild to moderate loss | People with normal hearing who want recreational amplification |
| Requires hearing test | Yes | No (but recommended) | No |
| Fitted by professional | Yes (audiologist or HIS) | No (self-fitting or preset) | No |
| Output limits | Set to audiogram, no regulatory cap | Capped by FDA rule for safety | None (no FDA performance standards) |
| Typical price per pair | $1,400–$7,000 (avg. ~$3,400 private pay) | $200–$1,500 (avg. ~$500) | $20–$300 |
| Clinical support | In-person follow-up, remapping, real-ear verification | Phone, chat, or video support | None |
| Can claim to treat hearing loss | Yes | Yes | No (prohibited by 21 CFR 800.30) |
| Return policy | State-mandated trial (30–45 days typical) | Retailer policy (45–100 days typical) | Retailer policy |
| Insurance eligible | Usually yes; HSA/FSA yes | Rarely; HSA/FSA yes | No |
Source: FDA Consumer Products: Hearing Aids, Over-the-Counter Hearing Aids final rule (87 FR 50698, October 17, 2022), and 21 CFR 800.30 (Restrictions on the sale, distribution, and use of hearing aid devices).
What is a PSAP?
A personal sound amplification product is a consumer electronic device that amplifies sound for people who do not have hearing loss. PSAPs are marketed for specific situational use: birdwatching, hunting, watching TV at low volume, attending lectures or live theater, or listening to distant conversations. They are not designed to compensate for impaired hearing, and they are not regulated as medical devices.
The FDA's guidance on PSAPs (issued February 2009, updated in draft guidance through the OTC rulemaking) makes the intended use clear: PSAPs are for consumers with normal hearing who want to amplify sounds in specific listening environments. They are not for people with hearing impairment, and manufacturers cannot market them as treatments for hearing loss without triggering medical device regulation.
In practice, the line between a PSAP and an OTC hearing aid is enforced through labeling, marketing, and claims. A device sold as "hear birds better on your hike" to a general audience is a PSAP. The same device sold as "improve your hearing" or "for people with hearing difficulty" becomes a medical device and must meet hearing aid standards.
PSAP rules and 21 CFR 800.30
PSAPs are restricted by 21 CFR 800.30, a regulation titled "Restrictions on the sale, distribution, and use of hearing aid devices." The rule was written before the OTC category existed, and its purpose is to prevent unregulated amplifiers from being sold as hearing loss treatments without meeting medical device standards.
21 CFR 800.30 requires that:
- A hearing aid (any device intended to compensate for impaired hearing) can only be sold to an individual with a written recommendation from a licensed physician or a signed waiver stating the individual is 18 or older and has declined medical evaluation.
- A hearing aid must include specific user instructional brochures that notify the user of conditions that should be evaluated by a physician before use.
PSAPs avoid these requirements by not claiming to treat hearing loss. The moment a manufacturer markets a PSAP to people with hearing impairment, it becomes a hearing aid under FDA regulations and must comply with all hearing aid rules or face enforcement.
The FDA has issued warning letters to manufacturers whose PSAP marketing crosses the line into medical claims, and the OTC rulemaking clarified that PSAPs remain a distinct category not subject to hearing aid performance standards.
When is a PSAP OK to use?
A PSAP is appropriate if:
- You have normal hearing confirmed by a hearing test within the past year.
- You want to amplify environmental sounds in specific situations (hunting, birdwatching, lectures, distant conversation at a large gathering).
- You do not struggle with background noise, do not ask people to repeat themselves regularly, and do not need the TV louder than others in your household.
A PSAP is not appropriate if:
- You have hearing loss or suspect you do. See the ten early signs of hearing loss.
- You struggle to follow conversation in noisy environments (restaurants, family gatherings).
- You have been told you have hearing loss by a doctor or audiologist.
- You are buying the device because "hearing aid" prices feel too high. That is cost avoidance, not a clinical reason to choose a PSAP, and you will end up with a device that cannot help you.
If you have hearing loss, the right device is an OTC hearing aid for mild to moderate loss or a prescription hearing aid for more severe or complex needs. PSAPs are not substitutes.
FDA registered vs. FDA cleared or authorized
Many PSAP advertisements include the phrase "FDA registered" or show an FDA logo. This language is misleading, and it is worth understanding what it does and does not mean.
FDA registration is an administrative requirement. Any establishment that manufactures, repackages, relabels, or imports medical devices must register with the FDA and list the devices it handles. Registration is not evidence that the FDA reviewed, tested, approved, or cleared the product. It is a paperwork requirement, not a quality endorsement.
PSAPs are not medical devices, so their manufacturers register as establishments that handle consumer products, not medical devices. A PSAP labeled "FDA registered" is registered in the same way a manufacturer of flashlights or kitchen timers is registered. The phrase does not mean the FDA evaluated the PSAP or determined it is safe or effective for hearing loss.
FDA clearance (510(k) for prescription hearing aids) and FDA authorization (De Novo or OTC rule compliance for over-the-counter hearing aids) mean the FDA reviewed the device's design, performance data, and labeling and determined it meets safety and effectiveness standards for its intended use as a medical device. This is a substantive review and a meaningful distinction.
Do not treat "FDA registered" as a quality badge or evidence of medical efficacy. It is not.
Quick decision guide
- If you have normal hearing and want to amplify environmental sounds for recreation (birdwatching, hunting, lectures), a PSAP is appropriate.
- If you have mild to moderate hearing loss, symmetric in both ears, and you are 18 or older, start with an OTC hearing aid. Choose a self-fitting model, not a preset. See our OTC comparison for 2026.
- If you have severe hearing loss, asymmetric loss, hearing loss under age 18, sudden or one-sided loss, ear pain, drainage, or dizziness, see an audiologist or ENT for a prescription hearing aid or medical evaluation. OTC and PSAP are both wrong for you.
- If you are unsure whether you have hearing loss, get a hearing test. See our signs of hearing loss guide and our decision guide for when to act.
Sources
- FDA Consumer Products: Hearing Aids (includes OTC vs. prescription vs. PSAP comparison table).
- FDA Over-the-Counter Hearing Aids final rule, 87 FR 50698, effective October 17, 2022. Federal Register.
- 21 CFR 800.30: Restrictions on the sale, distribution, and use of hearing aid devices. eCFR.
- FDA Draft Guidance for Industry and Food and Drug Administration Staff: Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification Products. Issued February 25, 2009 (updated through OTC rulemaking).
- 21 CFR 874.3300: Hearing aid. eCFR.